Reversal of Alzheimer’s Symptoms Within Minutes
An extraordinary new scientific study, which for the first time documents marked improvement in Alzheimer’s disease within minutes of administration of a therapeutic molecule, has just been published in the Journal of Neuroinflammation.
This new study highlights the importance of certain soluble proteins, called cytokines, in Alzheimer’s disease. The study focuses on one of these cytokines, tumor necrosis factor-alpha(TNF), a critical component of the brain’s immune system. Normally, TNF finely regulates the transmission of neural impulses in the brain. The authors hypothesized that elevated levels of TNF in Alzheimer’s disease interfere with this regulation. To reduce elevated TNF, the authors gave patients an injection of an anti-TNF therapeutic called etanercept. Excess TNF-alpha has been documented in the cerebrospinal fluid of patients with Alzheimer’s.
Help! I’m Sick. How Do I Handle My Diabetes?
Runny nose. Upset stomach. Whatever illness it is, it can make you feel miserable. It is hard enough to be under the weather but it is even more difficult to handle being sick if you have diabetes.
According to the American Diabetes Association (ADA), people with diabetes who develop an illness are at risk for serious complications if they don’t take care of their diabetes. Blood glucose levels can increase or decrease to dangerous levels if left unchecked. Ketones, a waste product created when the body begins to use stored fat for energy, can build up, especially in those with type 1 diabetes, if a person does not take insulin at regular intervals. Left unmonitored, high ketone levels can lead to ketoacidosis, which can lead to coma or death.
Newer Meningitis Vaccine Appears Safe and Effective for Infants
A vaccine not yet licensed in the United States produces immunity against four strains of meningococcal disease and is well tolerated when administered to infants, according to a study in the January 9/16 issue of JAMA.
It is estimated that 1,400 to 2,800 cases of invasive meningococcal disease occur in the United States each year, and that ten to 14 percent of people who contract the disease will die. The U.S. Advisory Committee on Immunization Practices now advises immunization with a tetravalent vaccine (serogroups A, C, W-135, and Y) for all 11- to 18-year-olds. However, the currently licensed vaccine is poorly immunogenic in infancy, when the highest rates of disease are observed, according to background information in the article.
